138 related articles for article (PubMed ID: 33818320)
1. Overexpression of long non-coding RNA urothelial carcinoma associated 1 causes paclitaxel (Taxol) resistance in colorectal cancer cells by promoting glycolysis.
Shi H; Li K; Feng J; Zhang X
J Chemother; 2021 Oct; 33(6):409-419. PubMed ID: 33818320
[TBL] [Abstract][Full Text] [Related]
2. Knockdown of LncRNA-UCA1 suppresses chemoresistance of pediatric AML by inhibiting glycolysis through the microRNA-125a/hexokinase 2 pathway.
Zhang Y; Liu Y; Xu X
J Cell Biochem; 2018 Jul; 119(7):6296-6308. PubMed ID: 29663500
[TBL] [Abstract][Full Text] [Related]
3. Long non-coding RNA UCA1 promotes the progression of paclitaxel resistance in ovarian cancer by regulating the miR-654-5p/SIK2 axis.
Li ZY; Wang XL; Dang Y; Zhu XZ; Zhang YH; Cai BX; Zheng L
Eur Rev Med Pharmacol Sci; 2020 Jan; 24(2):591-603. PubMed ID: 32016960
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of lncRNA-UCA1 suppresses pituitary cancer cell growth and prolactin (PRL) secretion via attenuating glycolysis pathway.
Liu G; Wang L; Li Y
In Vitro Cell Dev Biol Anim; 2020 Sep; 56(8):642-649. PubMed ID: 32909148
[TBL] [Abstract][Full Text] [Related]
5. Long non‑coding RNA urothelial cancer associated 1 regulates radioresistance via the hexokinase 2/glycolytic pathway in cervical cancer.
Fan L; Huang C; Li J; Gao T; Lin Z; Yao T
Int J Mol Med; 2018 Oct; 42(4):2247-2259. PubMed ID: 30015920
[TBL] [Abstract][Full Text] [Related]
6. LncRNA XIST Contributes to Cisplatin Resistance of Lung Cancer Cells by Promoting Cellular Glycolysis through Sponging miR-101-3p.
Hua G; Zeng ZL; Shi YT; Chen W; He LF; Zhao GF
Pharmacology; 2021; 106(9-10):498-508. PubMed ID: 34352791
[TBL] [Abstract][Full Text] [Related]
7. UCA1 involved in the metformin-regulated bladder cancer cell proliferation and glycolysis.
Li T; Sun X; Jiang X
Tumour Biol; 2017 Jun; 39(6):1010428317710823. PubMed ID: 28641488
[TBL] [Abstract][Full Text] [Related]
8. Long non-coding RNA UCA1 promotes glycolysis by upregulating hexokinase 2 through the mTOR-STAT3/microRNA143 pathway.
Li Z; Li X; Wu S; Xue M; Chen W
Cancer Sci; 2014 Aug; 105(8):951-5. PubMed ID: 24890811
[TBL] [Abstract][Full Text] [Related]
9. LncRNA UCA1 promotes proliferation and cisplatin resistance of oral squamous cell carcinoma by sunppressing miR-184 expression.
Fang Z; Zhao J; Xie W; Sun Q; Wang H; Qiao B
Cancer Med; 2017 Dec; 6(12):2897-2908. PubMed ID: 29125238
[TBL] [Abstract][Full Text] [Related]
10. Warburg effect in chemosensitivity: targeting lactate dehydrogenase-A re-sensitizes taxol-resistant cancer cells to taxol.
Zhou M; Zhao Y; Ding Y; Liu H; Liu Z; Fodstad O; Riker AI; Kamarajugadda S; Lu J; Owen LB; Ledoux SP; Tan M
Mol Cancer; 2010 Feb; 9():33. PubMed ID: 20144215
[TBL] [Abstract][Full Text] [Related]
11. TGF-β1 upregulates the expression of lncRNA UCA1 and its downstream HXK2 to promote the growth of hepatocellular carcinoma.
Hu ML; Wang XY; Chen WM
Eur Rev Med Pharmacol Sci; 2018 Aug; 22(15):4846-4854. PubMed ID: 30070319
[TBL] [Abstract][Full Text] [Related]
12. Expression of Long Noncoding RNA Urothelial Cancer Associated 1 Promotes Cisplatin Resistance in Cervical Cancer.
Wang B; Huang Z; Gao R; Zeng Z; Yang W; Sun Y; Wei W; Wu Z; Yu L; Li Q; Zhang S; Li F; Liu G; Liu B; Leng L; Zhan W; Yu Y; Yang G; Zhou S
Cancer Biother Radiopharm; 2017 Apr; 32(3):101-110. PubMed ID: 28414550
[TBL] [Abstract][Full Text] [Related]
13. LncRNA-SARCC sensitizes osteosarcoma to cisplatin through the miR-143-mediated glycolysis inhibition by targeting Hexokinase 2.
Wen JF; Jiang YQ; Li C; Dai XK; Wu T; Yin WZ
Cancer Biomark; 2020; 28(2):231-246. PubMed ID: 32508321
[TBL] [Abstract][Full Text] [Related]
14. Long Non-Coding RNA (lncRNA) Urothelial Carcinoma-Associated 1 (UCA1) Enhances Tamoxifen Resistance in Breast Cancer Cells via Inhibiting mTOR Signaling Pathway.
Wu C; Luo J
Med Sci Monit; 2016 Oct; 22():3860-3867. PubMed ID: 27765938
[TBL] [Abstract][Full Text] [Related]
15. Overexpression of miR-203 sensitizes paclitaxel (Taxol)-resistant colorectal cancer cells through targeting the salt-inducible kinase 2 (SIK2).
Liu Y; Gao S; Chen X; Liu M; Mao C; Fang X
Tumour Biol; 2016 Sep; 37(9):12231-12239. PubMed ID: 27236538
[TBL] [Abstract][Full Text] [Related]
16. Upregulated Long Noncoding RNA UCA1 Enhances Warburg Effect via miR-203/HK2 Axis in Esophagal Cancer.
Liu HE; Shi HH; Luo XJ
J Oncol; 2020; 2020():8847687. PubMed ID: 33204264
[TBL] [Abstract][Full Text] [Related]
17. Upregulation of long non-coding RNA urothelial carcinoma associated 1 by CCAAT/enhancer binding protein α contributes to bladder cancer cell growth and reduced apoptosis.
Xue M; Li X; Wu W; Zhang S; Wu S; Li Z; Chen W
Oncol Rep; 2014 May; 31(5):1993-2000. PubMed ID: 24648007
[TBL] [Abstract][Full Text] [Related]
18. Long Non-Coding RNA (LncRNA) Urothelial Carcinoma Associated 1 (UCA1) Increases Multi-Drug Resistance of Gastric Cancer via Downregulating miR-27b.
Fang Q; Chen X; Zhi X
Med Sci Monit; 2016 Oct; 22():3506-3513. PubMed ID: 27694794
[TBL] [Abstract][Full Text] [Related]
19. UCA1 confers paclitaxel resistance to ovarian cancer through miR-129/ABCB1 axis.
Wang J; Ye C; Liu J; Hu Y
Biochem Biophys Res Commun; 2018 Jul; 501(4):1034-1040. PubMed ID: 29777711
[TBL] [Abstract][Full Text] [Related]
20. The long non-coding RNA, urothelial carcinoma associated 1, promotes cell growth, invasion, migration, and chemo-resistance in glioma through Wnt/β-catenin signaling pathway.
Zhang B; Fang S; Cheng Y; Zhou C; Deng F
Aging (Albany NY); 2019 Oct; 11(19):8239-8253. PubMed ID: 31596734
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
